Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship

ASHLEY WILSON, JAMES SMALL, CATHERINE FLANAGAN, DAVID PERRY, RICHARD MARCHELL, BRUCE THIERS and ANTHONY J. ALBERG
Anticancer Research September 2019, 39 (9) 5083-5087; DOI: https://doi.org/10.21873/anticanres.13702
ASHLEY WILSON
1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAMES SMALL
2Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CATHERINE FLANAGAN
1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID PERRY
3Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RICHARD MARCHELL
3Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRUCE THIERS
3Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTHONY J. ALBERG
1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, U.S.A.
2Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, U.S.A.
4Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, SC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alberg{at}mailbox.sc.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 9 5083-5087
DOI 
https://doi.org/10.21873/anticanres.13702
PMID 
31519619

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 11, 2019
  • Revision received July 19, 2019
  • Accepted July 22, 2019
  • Published online September 13, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ASHLEY WILSON1,
  2. JAMES SMALL2,
  3. CATHERINE FLANAGAN1,
  4. DAVID PERRY3,
  5. RICHARD MARCHELL3,
  6. BRUCE THIERS3 and
  7. ANTHONY J. ALBERG1,2,4⇑
  1. 1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, U.S.A.
  2. 2Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, U.S.A.
  3. 3Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, U.S.A.
  4. 4Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, SC, U.S.A.
  1. Correspondence to: Anthony J. Alberg, Ph.D., MPH, Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, 915 Greene Street, Columbia, SC 29208, U.S.A. Tel: +1 8037776220, e-mail: alberg{at}mailbox.sc.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 39, Issue 9
September 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship
ASHLEY WILSON, JAMES SMALL, CATHERINE FLANAGAN, DAVID PERRY, RICHARD MARCHELL, BRUCE THIERS, ANTHONY J. ALBERG
Anticancer Research Sep 2019, 39 (9) 5083-5087; DOI: 10.21873/anticanres.13702

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship
ASHLEY WILSON, JAMES SMALL, CATHERINE FLANAGAN, DAVID PERRY, RICHARD MARCHELL, BRUCE THIERS, ANTHONY J. ALBERG
Anticancer Research Sep 2019, 39 (9) 5083-5087; DOI: 10.21873/anticanres.13702
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort
  • Dual Modality and Site-differentiated Sentinel Node Mapping in Vulvar Cancer
  • Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer
Show more Clinical Studies

Keywords

  • Keratinocyte carcinoma
  • nonmelanoma skin cancer
  • case-control study
  • epidemiology
  • cancer risk
  • second primary cancers
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire